Eradicating Insomnia In The Over 55's If you're over 55 and have spent more than a few sleepless nights, you're not alone -- insomnia affects about half of all people over 55 -- but you may also be at increased risk for physical and mental ailments.
Source: www.medicalnewstoday.comThe Multiple Myeloma Research Consortium Announces Initiation Of First Four-Drug Combination Study To Treat Newly Diagnosed Multiple Myeloma Patients The Multiple Myeloma Research Consortium (MMRC) announced the initiation of a four-drug combination study with REVLIMID® (lenalidomide), VELCADE® (bortezomib) for Injection, DOXIL® (doxorubicin HCl liposome injection) and dexamethasone for the treatment of multiple myeloma in patients who are previously untreated.
Source: www.medicalnewstoday.comResults From The PRECISION V Clinical Trial Biocompatibles is pleased to announce the headline results from the PRECISION V clinical trial. A more complete presentation of the results will take place as planned at CIRSE (Cardiovascular and Interventional Radiological Society of Europe) 2008, September 13-17, 2008, Copenhagen. A further announcement will be made at that time.
Source: www.medicalnewstoday.comGenetics Policy Institute Announces 2008 "Stem Cell Action" Honorees To Be Recognized At The World Stem Cell Summit, Madison The Genetics Policy Institute (GPI) will hold its annual Stem Cell Action Awards dinner on Monday, September 22, at Alliant Energy Center as part of the 2008 World Stem Cell Summit in Madison, Wisconsin. The 2008 awards dinner is underwritten by Promega Corporation.
Source: www.medicalnewstoday.comUNICEF Responds To Immediate Needs Of Displaced Children And Women In Georgia UNICEF and its partners have distributed hygiene kits and bottled water to 3,600 displaced women and children in and around the Georgian capital, Tbilisi. UNICEF, and other international humanitarian agencies, are currently conducting rapid assessments to identify the scale of problems and the most pressing needs of affected people, including children.
Source: www.medicalnewstoday.comGlobal Phase 3 Study Of IMC-1121B In Metastatic Breast Cancer Commences ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that the first patient has been treated in a global Phase 3 clinical trial of IMC-1121B, its anti-vascular endothelial growth factor receptor-2 (VEGFR-2) IgG1 monoclonal antibody, in women with metastatic breast cancer.
Source: www.medicalnewstoday.comGenentech Special Committee Of Independent Directors Responds To Roche Proposal The special committee of the Board of Directors of Genentech, Inc. (NYSE:DNA) announced that, after careful consideration, it has unanimously concluded that Roche's proposal to acquire the shares of Genentech not owned by Roche for $89.00 per share substantially undervalues the company. Therefore, the special committee does not support the proposal.
Source: www.medicalnewstoday.comSurgical Weight Loss Does Not Eliminate Obstructive Sleep Apnea A study in the Journal of Clinical Sleep
Medicine shows that surgical weight loss results in an improvement of obstructive sleep apnea (OSA), but most patients continue to have moderate to severe OSA one year after undergoing bariatric surgery. .
Source: www.medicalnewstoday.com
# posted by Network @ 8:00 AM
